Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats

Food and Chemical Toxicology

Volumn 48, Issue 3, 2010, Pages 951-956

  Alkreathy, Huda ^a   Damanhouri, Zoheir A ^a   Ahmed, Nessar ^b   Slevin, Mark ^b   Ali, Soad S ^a   Osman, Abdel Moneim M ^a  

^a Aziz University   (Saudi Arabia)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Aged garlic extract; Cardiotoxicity; Doxorubicin

Indexed keywords

CREATINE KINASE; DOXORUBICIN; FREE RADICAL; GARLIC EXTRACT; LACTATE DEHYDROGENASE; MALONALDEHYDE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; LUNG EDEMA; MALE; NONHUMAN; POLYARTERITIS NODOSA; RAT; SINGLE DRUG DOSE; TISSUE STRUCTURE; VASODILATATION; VENOUS CONGESTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; DOXORUBICIN; GARLIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART DISEASES; INDICATORS AND REAGENTS; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MYOCARDIUM; MYOCYTES, CARDIAC; PLANT EXTRACTS; RATS; RATS, WISTAR;

ALLIUM SATIVUM; RATTUS;

EID: 76749121330     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.01.005     Document Type: Article

References (40)

1. Ackermann R.T., Mulrow C.D., Ramirez G., Gardner C.D., Morbidoni L., and Lawrence V.A. Garlic shows promise for improving some cardiovascular risk factors. Arch. Inter. Med. 161 (2001) 813-824
2. Al-Majed A.A., Gado A., Al-Shabanah O.A., and Mansour M.A. Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin. Pharmacol. Res. 46 (2002) 499-503
3. Al-Numair K.S. Hypocholesteremic and antioxidant effects of garlic (Allium sativum L.) extract in rats fed high cholesterol diet. Pak. J. Nutr. 8 (2009) 161-166
4. Amagase H., Petesch B.L., Matsuura H., Kasuga S., and Itakura Y. Intake of garlic and its bioactive components. J. Nutr. 131 (2001) 955S-962S
5. Bagchi D., Bagchi M., Hassoun E.A., Kelly J., and Stohs S.J. Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology 95 (1995) 1-9
6. Banerjee S.K., Dinda A.K., Manchanda S.C., and Maulik S.K. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol. 2 (2002)
7. Banerjee S.K., Maulik M., Mancahanda S.C., Dinda A.K., Gupta S.K., and Maulik S.K. Dose-dependent induction of endogenous antioxidants in rat heart by chronic administration of garlic. Life Sci. 70 (2002) 1509-1518
8. Banerjee S.K., Mukherjee P.K., and Maulik S.K. Garlic as an antioxidant: the good, the bad and the ugly. Phytother. Res. 17 (2003) 97-106
9. Borek C. Antioxidant health effects of aged garlic extract. J. Nutr. 131 (2001) 1010S-1015S
10. Davies K.J., and Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261 (1986) 3060-3067
11. De Beer E.L., Bottone A.E., and Voest E.E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur. J. Pharmacol. 415 (2001) 1-11
12. Demirkaya E., Avci A., Kesik V., Karslioglu Y., Ozatas E., Kismet E., Gokcay E., Durak I., and Koseoglu V. Cardioprotective roles of aged garlic extract, grape seed proanthcyanidine and hazelnut on doxorubicin-induced cardiotoxicity. Can. J. Physiol. Pharmcol. 87 8 (2009) 633-640
13. Dillon S.A., Burmi R.S., Lowe G.M., Billington D., and Rahman K. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein. Life Sci. 72 (2003) 1583-1594
14. Gorinstein S., Leontowicz H., Leontowicz M., Drzewiecki J., Najman K., Katrich E., Barasch D., Yamamoto K., and Trakhtenberg S. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci. 78 (2006) 655-663
15. Hemnani T., and Parihar M.S. Reactive oxygen species and oxidative DNA damage. Ind. J. Physiol. Pharmacol. 42 (1998) 440-452
16. Henery, R.J., 1974. Colorimetric determination of lactic dehydrogenase. In: Henery, R.J. (Ed.). Clinical Chemistry : Principles and Techniques. Second ed. Harper & Row. Hagerstown MD, pp. 819-831.
17. Horie T., Murayama T., Mishima T., Itoh F., Minamide Y., Fuwa T., and Awazu S. Protection of liver microsomal membranes from lipid peroxidation by garlic extract. Planta Med. 55 (1989) 506
18. Imai J., Ide N., Nagae S., Moriguchi T., Matsuura H., and Itakura Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med. 60 (1994) 417-420
19. Kailash C.A. Therapeutic actions of garlic constituents. Med. Res. Rev. 16 (1996) 111-124
20. Kasuga S., Uda N., Kyo E., Ushijima M., Morihara N., and Itakura Y. Pharmacologic activities of aged garlic extract in comparison with other garlic preparations. J. Nutr. 131 (2001) 1080S-1084S
21. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. (Lond.) 84 (1993) 407-412
22. Monnet E., and Christopher O. A canine model of heart failure by intracoronary adriamycin injection: hemodynamic and energetic results. J. Card. Fail. 5 (1999) 255-264
23. Mukherjee S., Banerjee S.K., Maulik M., Dinda A.K., Talwar K.K., and Maulik S.K. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-a expression. BMC Pharmacol. 3 (2003)
24. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., and Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197 (1977) 165-167
25. Nagi M.N., and Mansour M.A. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 41 (2000) 283-289
26. Olson R.D., and Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4 (1990) 3076-3086
27. Pacher P., Liaudet L., Bai P., Bai P., Mabley J., Kaminiski P., Virag L., Deb A., Szabo E., Ungvari Z., Wolion M., Groves J., and Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107 (2003) 896-904
28. Preus M., Bhargava A.S., Khater A.E., and Günzel P. Diagnostic value of serum creatine kinase and lactate dehydrogenase isoenzyme determinations for monitoring early cardiac damage in rats. Toxicol. Lett. 42 (1988) 225
29. Rahman K. Historical perspective on garlic and cardiovascular disease. J. Nutr. 131 (2001) 977S-979S
30. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann. Intern. Med. 125 (1996) 47-58
31. Shuai Y.I., Guo I.B., Peng S.-G., Zhang L.-S., Guo J., Han G., and Shen Dong Y. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment. Toxicol. Lett. 170 11 (2007) 66-74
32. 2+ binding and lipid peroxidation but depresses myocardial function. Am. J. Physiol.-Heart Circul. Physiol. 250 (1986) 419-425
33. Siveski-Iliskovic N., Hill M., Chow D.A., and Singal P.K. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91 (1995) 10-15
34. Sparano J.A. Use of Dexrazoxane and other Strategies to Prevent Cardiomyopathy Associated with Doxorubicin-Taxane Combinations (1998), Grune and Stratton, New York pp. 66-71
35. Speyer J.L., Green M.D., Zeleniuch-Jacquotte A., Wernz J.C., Rey M., Sanger J., Kramer E., Ferrans V., Hochster H., and Meyers M. ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J. Clin. Oncol. 10 (1992) 867
36. Sugioka K., and Nakano M. Mechanism of phospholipid peroxidation induced by ferric ion-ADP-adriamycin-co-ordination complex. Biochim. Biophys. Acta 713 (1982) 333-343
37. Tesoriere L., Ciaccio M., Valenza M., Bongiorno A., Maresi E., Albiero R., and Livrea M.A. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality. J. Pharmacol. Exp. Ther. 269 (1994) 430-436
38. Van Vleet J.F., Ferrans V.J., and Weirich W.E. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. Am. J. Pathol. 99 (1980) 13-42
39. Yagmurca M., Fadillioglu E., Erdogan H., Ucar M., Sogut S., and Irmak M.K. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol. Res. 48 (2003) 377-382
40. Yoda Y. Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione. Cancer Res. 46 (1986) 2551-2556